Patent directory · USPTO A61K / A61P
Patents matching “BOARD OF REGENTS”
2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10881720
Nanoparticles for immune stimulation
granted -
US 10881708
Ang (1-7) derivative oligopeptides for the treatment of pain
granted -
US 10883094
Transposase polypeptides and uses thereof
granted -
US 10881735
Phase change nanodroplet conjugates for targeted delivery
granted -
US 10881630
Creatine oral supplementation using creatine hydrochloride salt
granted -
US 10882903
Methods and compositions for treating an alphavirus infection
granted -
US 10875912
EGFL6 specific monoclonal antibodies and methods of their use
granted -
US 10874752
MIBG analogs and uses thereof
granted -
US 10874622
Dual assembly nanoparticles
granted -
US 10874631
Altertoxin II as a selective inhibitor of Ewing family of tumor cells
granted -
US 10875920
Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof
granted -
US 10876116
Anti-ARID3a treatments for inflammatory disorders
granted -
US 10874334
Methods and systems for quantification of blood-brain barrier permeation of glycosylated peptides
granted -
US 10876134
Gene therapy for juvenile batten disease
granted -
US 10869871
Compositions and methods of modulating short-chain dehydrogenase activity
granted -
US 10870854
Inhibitory RNA-based therapeutics targeting ANLN for cancer treatment
granted -
US 10865403
Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
granted -
US 10858410
Glycosylated peptides with pseudoproline residues and having enhanced half-lives and ability to cross the blood brain barrier
granted -
US 10858416
Methods and compositions for modification of a HLA locus
granted -
US 10857382
Compositions and methods for treating and preventing chronic pain
granted -
US 10858432
Antibodies specific to glycosylated PD-1 and methods of use thereof
granted -
US 10851173
Anti-OX40 antibodies and methods of using the same
granted -
US 10849875
Cancer specific lipid targeted peptidomimetics
granted -
US 10851110
Heterocyclic inhibitors of PTPN11
granted